CERTAIN RHEUMATOID FACTORS REACT WITH BOTH IGG AND AN ANTIGEN ASSOCIATED WITH CELL NUCLEI.HANNESTAD K.1978; SCAND. J. IMMUNOL.; NORWAY; DA. 1978; VOL. 7; NO 2; PP. 127-136; BIBL. 24 REF.Article

HELPER T CELL RECOGNITION OF THE VARIABLE DOMAINS OF A MOUSE MYELOMA PROTEIN (315): EFFECT OF THE MAJOR HISTOCOMPATIBILITY COMPLEX AND DOMAIN CONFORMATIONJORGENSEN T; HANNESTAD K.1982; JOURNAL OF EXPERIMENTAL MEDICINE; ISSN 0022-1007; USA; DA. 1982; VOL. 155; NO 6; PP. 1587-1596; BIBL. 37 REF.Article

LIGAND-INDUCED REDISTRIBUTION AND AUGMENTATION OF SURFACE-BOUND MYELOMA PROTEIN ON MOPC 315 PLASMACYTOMA CELLS.HANNESTAD K; GAUDERNACK G.1977; SCAND. J. IMMUNOL.; NORWAY; DA. 1977; VOL. 6; NO 1-2; PP. 59-76; BIBL. 1 P. 1/2Article

ACID ELUTION OF BLOOD GROUP ANTIBODIES FROM INTACT ERYTHROCYTES.REKVIG OP; HANNESTAD K.1977; VOX SANG.; SUISSE; DA. 1977; VOL. 33; NO 5; PP. 280-285; BIBL. 14 REF.Article

BINDING OF LIGANDS TO A MONOCLONAL IGM MACROGLOBULIN WITH MULTIPLE SPECIFICITYTOLLESHAUG H; HANNESTAD K.1975; IMMUNOCHEMITRY; G.B.; DA. 1975; VOL. 12; NO 2; PP. 173-182; BIBL. 1P.Article

THE PLASMA CELL DIFFERNETIATION ANTIGEN PC.1 IS ABSENT IN CH3/TIF AND PRESENT IN C3H/HEJGAUDERNACK G; HANNESTAD K.1979; SCAND. J. IMMUNOL.; NOR; DA. 1979; VOL. 9; NO 4; PP. 373-379; BIBL. 16 REF.Article

CERTAIN RHEUMATOID FACTORS REACT WITH NUCLEOSOMESHANNESTAD K; STOLLAR BD.1978; NATURE; GBR; DA. 1978; VOL. 275; NO 5681; PP. 671-673; BIBL. 18 REF.Article

H-2-LINKED GENES CONTROL IMMUNE RESPONSE TO V-DOMAINS OF MYELOMA PROTEIN 315JORGENSEN T; HANNESTAD K.1980; NATURE (LOND.); ISSN 0028-0836; GBR; DA. 1980; VOL. 288; NO 5789; PP. 396-397; BIBL. 17 REF.Article

HUMAN AUTOANTIBODIES THAT REACT WITH BOTH CELL NUCLEI AND PLASMA MEMBRANES DISPLAY SPECIFICITY FOR THE OCTAMER OF HISTONES H2A, H2B, H3, AND H4 IN HIGH SALTREKVIG OP; HANNESTAD K.1980; J. EXP. MED.; ISSN 0022-1007; USA; DA. 1980; VOL. 152; NO 6; PP. 1720-1733; BIBL. 44 REF.Article

POLYCLONAL HUMAN ANTIBODIES TO IGG (RHEUMATOID FACTORS) WHICH CROSS-REACT WITH CELL NUCLEI.HANNESTAD K; JOHANNESSEN A.1976; SCAND. J. IMMUNOL.; NORWAY; DA. 1976; VOL. 5; NO 5; PP. 541-547; BIBL. 19 REF.Article

LUPUS ERYTHEMATOSUS (LE) FACTORS RECOGNIZE BOTH NUCLEOSOMES AND VIABLE HUMAN LEUCOCYTESREKVIG OP; HANNESTAD K.1981; SCAND. J. IMMUNOL.; ISSN 0300-9475; NOR; DA. 1981; VOL. 13; NO 6; PP. 597-604; BIBL. 30 REF.Article

T HELPER LYMPHOCYTES RECOGNIZE THE V_L DOMAIN OF THE ISOLOGOUS MOUSE MYELOMA PROTEIN 315JORGENSEN T; HANNESTAD K.1979; SCAND. J. IMMUNOL.; NOR; DA. 1979; VOL. 10; NO 4; PP. 317-323; BIBL. 21 REF.Article

PROPERTIES OF ANTINUCLEAR ANTIBODIES THAT CROSS-REACT WITH PLASMA MEMBRANESREKVIG OP; HANNESTAD K.1979; SCAND. J. IMMUNOL.; NOR; DA. 1979; VOL. 9; NO 4; PP. 325-332; BIBL. 18 REF.Article

THE SPECIFICITY OF HUMAN AUTOANTIBODIES THAT REACT WITH BOTH CELL NUCLEIC AND PLASMA MEMBRANES: THE NUCLEAR ANTIGEN IS PRESENT ON CORE MONONUCLEOSOMESREKVIG OP; HANNESTAD K.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 123; NO 6; PP. 2673-2681; BIBL. 40 REF.Article

CERTAIN POLYCLONAL ANTINUCLEAR ANTIBODIES CROSS-REACT WITH THE SURFACE MEMBRANE OF HUMAN LYMPHOCYTES AND GRANULOCYTES.REKVIG OP; HANNESTAD K.1977; SCAND. J. IMMUNOL.; NORWAY; DA. 1977; VOL. 6; NO 10; PP. 1041-1054; BIBL. 2 P. 1/2Article

SPECIFICITY OF T AND B LYMPHOCYTES FOR MYELOMA PROTEIN 315.JORGENSEN T; HANNESTAD K.1977; EUROP. J. IMMUNOL.; GERM.; DA. 1977; VOL. 7; NO 7; PP. 426-431; BIBL. 26 REF.Article

PRODUCTION OF BALB/C ANTI-IDIOTYPIC ANTIBODIES AGAINST THE BALB/C MYELOMA PROTEIN 315 DOES NOT REQUIRE AN INTACT LIGAND-BINDING SITE.JORGENSEN T; GAUDERNACK G; HANNESTAD K et al.1977; SCAND. J. IMMUNOL.; NORWAY; DA. 1977; VOL. 6; NO 4; PP. 311-318; BIBL. 31 REF.Article

HISTONES SYNTHESIZED FOR USE IN EARLY DEVELOPMENT OF XENOPUS LAEVIS ARE STORED AS A COMPLEX WITH ANTIGENIC PROPERTIES SIMILAR TO THOSE OF THE OCTAMER CORE OF NUCLEOSOMESEARNSHAW WC; REKVIG OP; HANNESTAD K et al.1982; J. CELL BIOL.; ISSN 0021-9525; USA; DA. 1982; VOL. 92; NO 3; PP. 871-876; BIBL. 30 REF.Article

CELL-BOUND MYELOMA PROTEINS ON THE SURFACE OF MYELOMA CELLS: POTENTIAL TARGETS FOR THE IMMUNE SYSTEMHANNESTAD K; MING SHIAN KAO; EISEN HN et al.1972; PROC. NATION. ACAD. SCI. U.S.A.; U.S.A.; DA. 1972; VOL. 69; NO 8; PP. 2295-2299; BIBL. 27 REF.Serial Issue

IMMUNIZATION WITH THE LIGHT CHAIN AND THE V_L DOMAIN OF THE ISOLOGOUS MYELOMA PROTEIN 315 INHIBITS GROWTH OF MOUSE PLASMACYTOMA MOPC315JORGENSEN T; GAUDERNACK G; HANNESTAD K et al.1980; SCAND. J. IMMUNOL.; NOR; DA. 1980; VOL. 11; NO 1; PP. 29-35; BIBL. 16 REF.Article

Direct HLA typing by rosetting with immunomagnetic beads coated with specific antibodiesHANSEN, T; HANNESTAD, K.Journal of immunogenetics. 1989, Vol 16, Num 2, pp 137-139, issn 0305-1811Article

Immune responses to an adjuvant-free native syngeneic myeloma protein (M315)KRISTOFFERSEN, G; HANNESTAD, K.European journal of immunology. 1988, Vol 18, Num 11, pp 1785-1790, issn 0014-2980Article

A supertypic HLA-DP specificity defined by two human-human hybridoma antibodies (TrBSO;TrE11)KOLSTAD, A; HANNESTAD, K.Human immunology. 1989, Vol 25, Num 4, pp 247-256, issn 0198-8859Article

IN VIVO GROWTH ADVANTAGE OF THE MOPC-315 MOUSE MYELOMA OVER ITS IMMUNOSELECTED VARIANTS.HANNESTAD K; MING SHIAN KAO; LYNCH RG et al.1977; J. NATION. CANCER INST.; U.S.A.; DA. 1977; VOL. 59; NO 4; PP. 1307-1310; BIBL. 8 REF.Article

A cytotoxic human hybridoma monoclonal antibody (TrJ6) defining an epitope expressed by HLA-DQ4 and -DQ5JUN GE; HANNESTAD, K.Human immunology. 1994, Vol 39, Num 2, pp 106-112, issn 0198-8859Conference Paper